This article first appeared on GuruFocus.

Orthofix Medical Inc (NASDAQ:OFIX) is set to release its Q3 2025 earnings on Nov 4, 2025. The consensus estimate for Q3 2025 revenue is $200.01 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $813.56 million and the earnings are expected to be -$2.22 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 7 Warning Signs with OFIX.

Is OFIX fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Orthofix Medical Inc (NASDAQ:OFIX) have increased from $813.50 million to $813.56 million for the full year 2025 and increased from $856.91 million to $859.60 million for 2026 over the past 90 days. Earnings estimates for Orthofix Medical Inc (NASDAQ:OFIX) have increased from -$2.39 per share to -$2.22 per share for the full year 2025 and declined from -$1.40 per share to -$1.58 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, Orthofix Medical Inc's (NASDAQ:OFIX) actual revenue was $203.12 million, which beat analysts' revenue expectations of $196.89 million by 3.16%. Orthofix Medical Inc's (NASDAQ:OFIX) actual earnings were -$0.36 per share, which beat analysts' earnings expectations of -$0.49 per share by 26.53%. After releasing the results, Orthofix Medical Inc (NASDAQ:OFIX) was up by 13.46% in one day.

Based on the one-year price targets offered by 4 analysts, the average target price for Orthofix Medical Inc (NASDAQ:OFIX) is $22.55 with a high estimate of $27.20 and a low estimate of $17.00. The average target implies an upside of 45.86% from the current price of $15.46.

Based on GuruFocus estimates, the estimated GF Value for Orthofix Medical Inc (NASDAQ:OFIX) in one year is $16.65, suggesting an upside of 7.70% from the current price of $15.46.

Based on the consensus recommendation from 5 brokerage firms, Orthofix Medical Inc's (NASDAQ:OFIX) average brokerage recommendation is currently 1.6, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.